{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:53:27Z","timestamp":1792612407173,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL124392"],"award-info":[{"award-number":["R01 HL124392"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR44883"],"award-info":[{"award-number":["R01 AR44883"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jid.2017.08.024","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T03:00:35Z","timestamp":1504321235000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Therapeutic Targeting of TAZ and YAP by\u00a0Dimethyl Fumarate in Systemic Sclerosis\u00a0Fibrosis"],"prefix":"10.1016","volume":"138","author":[{"given":"Tetsuo","family":"Toyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka P.","family":"Looney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon M.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Stawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander D.","family":"Szymaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xaralabos","family":"Varelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.08.024_bib1","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2017.08.024_bib2","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.4049\/jimmunol.175.11.7708","article-title":"Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts","volume":"175","author":"Asano","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.08.024_bib3","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.21246","article-title":"Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts","volume":"52","author":"Asano","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.08.024_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2017.08.024_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jid.2017.08.024_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4161\/15384047.2014.967992","article-title":"Regulation of dimethyl-fumarate toxicity by proteasome inhibitors","volume":"15","author":"Booth","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jid.2017.08.024_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2230.2007.02389.x","article-title":"Fumaric acid esters in the management of severe psoriasis","volume":"32","author":"Brewer","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2017.08.024_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jid.2017.08.024_bib9","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.1101868","article-title":"Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection","volume":"187","author":"Cross","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.08.024_bib10","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1096\/fasebj.13.13.1774","article-title":"Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP","volume":"13","author":"Duncan","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2017.08.024_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jid.2017.08.024_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00109-014-1190-x","article-title":"Molecular and cellular basis of scleroderma","volume":"92","author":"Eckes","year":"2014","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jid.2017.08.024_bib12","first-page":"1674","article-title":"Integrin signalling regulates YAP and TAZ to control skin homeostasis","volume":"143","author":"Elbediwy","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.jid.2017.08.024_bib13","doi-asserted-by":"crossref","first-page":"27928","DOI":"10.1074\/jbc.M115.692285","article-title":"TAZ protein accumulation is negatively regulated by YAP abundance in mammalian cells","volume":"290","author":"Finch-Edmondson","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2017.08.024_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","article-title":"A\u00a0common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation","volume":"7","author":"Frame","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.jid.2017.08.024_bib15","first-page":"291","article-title":"Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1","volume":"23","author":"Giacomelli","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2017.08.024_bib16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2017.08.024_bib17","doi-asserted-by":"crossref","first-page":"41605","DOI":"10.1038\/srep41605","article-title":"Dimethyl fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways","volume":"7","author":"Grzegorzewska","year":"2017","journal-title":"Sci Rep"},{"issue":"pt 9","key":"10.1016\/j.jid.2017.08.024_bib18","first-page":"2276","article-title":"PDGFRbeta expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation","volume":"125","author":"Hewitt","year":"2012","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jid.2017.08.024_bib19","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1074\/jbc.M113.529115","article-title":"The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells","volume":"289","author":"Hiemer","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2017.08.024_bib20","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1074\/jbc.M112.382036","article-title":"The N-terminal phosphodegron targets TAZ\/WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition","volume":"287","author":"Huang","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2017.08.024_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1091\/mbc.4.6.637","article-title":"Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair","volume":"4","author":"Igarashi","year":"1993","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jid.2017.08.024_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jid.2017.08.024_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2017.08.024_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1083\/jcb.201501025","article-title":"Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway","volume":"210","author":"Kim","year":"2015","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jid.2017.08.024_bib25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta\u2014at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2017.08.024_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.27307","article-title":"Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis","volume":"62","author":"Lagares","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.08.024_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00281-015-0508-2","article-title":"Matrix remodeling in systemic sclerosis","volume":"37","author":"Leask","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2017.08.024_bib28","doi-asserted-by":"crossref","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","article-title":"The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase","volume":"285","author":"Liu","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2017.08.024_bib29","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jid.2017.08.024_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/jid.2012.264","article-title":"A\u00a0role for estrogen receptor-alpha and estrogen receptor-beta in collagen biosynthesis in mouse skin","volume":"133","author":"Markiewicz","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.08.024_bib31","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/onc.2011.363","article-title":"Integrating developmental signals: a Hippo in the (path)way","volume":"31","author":"Mauviel","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.08.024_bib32","first-page":"1626","article-title":"Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study","volume":"263","author":"Miclea","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jid.2017.08.024_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/JID.2015.361","article-title":"Dimethylfumarate impairs neutrophil functions","volume":"136","author":"Muller","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.08.024_bib34","doi-asserted-by":"crossref","first-page":"e45870","DOI":"10.1371\/journal.pone.0045870","article-title":"Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta\/Smad signaling","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.08.024_bib35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.redox.2014.06.003","article-title":"Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms","volume":"2","author":"Oh","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/j.jid.2017.08.024_bib36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"Ohlund","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.08.024_bib37","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/art.23698","article-title":"Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate","volume":"58","author":"Pannu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.08.024_bib38","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1002\/art.22063","article-title":"Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: a model of scleroderma","volume":"54","author":"Pannu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.08.024_bib39","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1074\/jbc.M611742200","article-title":"Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1\/2 pathways","volume":"282","author":"Pannu","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2017.08.024_bib40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jid.2017.08.024_bib41","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1091\/mbc.e03-12-0902","article-title":"Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac\/phosphoinositide 3-kinase\/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts","volume":"15","author":"Shi-Wen","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jid.2017.08.024_bib42","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar4028","article-title":"Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis","volume":"14","author":"Stawski","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2017.08.024_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1440-169X.2009.01141.x","article-title":"Glycogen synthase kinase 3 in the world of cell migration","volume":"51","author":"Sun","year":"2009","journal-title":"Dev Growth Differ"},{"key":"10.1016\/j.jid.2017.08.024_bib44","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1681\/ASN.2015050499","article-title":"YAP\/TAZ are mechanoregulators of TGF-beta-Smad signaling and renal fibrogenesis","volume":"27","author":"Szeto","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jid.2017.08.024_bib45","first-page":"1534","article-title":"Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor","volume":"25","author":"Takemura","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2017.08.024_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e32833038ce","article-title":"Noncanonical transforming growth factor beta signaling in scleroderma fibrosis","volume":"21","author":"Trojanowska","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2017.08.024_bib47","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1242\/dev.102376","article-title":"The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease","volume":"141","author":"Varelas","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.jid.2017.08.024_bib48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ncb1748","article-title":"TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal","volume":"10","author":"Varelas","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jid.2017.08.024_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.trsl.2016.12.002","article-title":"Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative","volume":"183","author":"Wei","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.jid.2017.08.024_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2010.12.033","article-title":"Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3beta","volume":"144","author":"Wu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.08.024_bib51","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.ajpath.2014.06.027","article-title":"Glycogen synthase kinase 3beta dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy","volume":"184","author":"Xu","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2017.08.024_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cm.20041","article-title":"Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion","volume":"60","author":"Yeung","year":"2005","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.jid.2017.08.024_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A\u00a0coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17329196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17329196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:11:04Z","timestamp":1758301864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17329196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0022202X17329196"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.08.024","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Targeting of TAZ and YAP by\u00a0Dimethyl Fumarate in Systemic Sclerosis\u00a0Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}